Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             104 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model Greenbaum, Lior
 2012
 22 Supplement 2 p. 379-386
8 p.
 artikel
2 Anhedonia and major depression: The role of agomelatine Di Giannantonio, Massimo
 2012
 22 Supplement 2 p. S505-S510
6 p.
 artikel
3 Association between the dexamethasone suppression test and serotonin transporter availability in healthy volunteers — A SPECT with [123I] ADAM study Tsai, Hsiang-Yi
 2012
 22 Supplement 2 p. 641-646
6 p.
 artikel
4 A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: A three-center double-blind placebo-controlled study Koychev, Ivan
 2012
 22 Supplement 2 p. 469-481
13 p.
 artikel
5 Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial Friedman, Edward S.
 2012
 22 Supplement 2 p. 183-199
17 p.
 artikel
6 C.12.02 Engaging patients in the treatment of alcohol dependence – The role of reduction of alcohol consumption and “as-needed” dosing Gual, A.
 2012
 22 Supplement 2 p. S450-
1 p.
 artikel
7 C.01.01 From strength to strength – Escitalopram the cornerstone of treatment in depression Barak, Y.
 2012
 22 Supplement 2 p. S441-
1 p.
 artikel
8 Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor de Bartolomeis, Andrea
 2012
 22 Supplement 2 p. 527-535
9 p.
 artikel
9 Clozapine resistance: Augmentation strategies Porcelli, Stefano
 2012
 22 Supplement 2 p. 165-182
18 p.
 artikel
10 Concomitant blockade of 5-HT1A receptor and 5-HT transporter: Use of the Hunter Serotonin Toxicity Criteria in a clinical pharmacology study Parks, V.
 2012
 22 Supplement 2 p. 92-99
8 p.
 artikel
11 Contents 2012
 22 Supplement 2 p. OBC-
1 p.
 artikel
12 C.04.02 What are the next steps? Combating inadequate response in MDD Thase, M.
 2012
 22 Supplement 2 p. S444-S445
2 p.
 artikel
13 Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR? Baldwin, David S.
 2012
 22 Supplement 2 p. 137-142
6 p.
 artikel
14 Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: Comparison with transient local inactivation Creed, Meaghan C.
 2012
 22 Supplement 2 p. 506-517
12 p.
 artikel
15 E.07.02 How to improve rodent models of common neuropsychiatric disorders Fone, K.C.F.
 2012
 22 Supplement 2 p. S152-
1 p.
 artikel
16 Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain Ghanbari, Ramez
 2012
 22 Supplement 2 p. 518-526
9 p.
 artikel
17 E.05.02 The unmet needs in the treatment of unipolar depression Kasper, S.
 2012
 22 Supplement 2 p. S151-
1 p.
 artikel
18 Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo Robson, Matthew J.
 2012
 22 Supplement 2 p. 308-317
10 p.
 artikel
19 Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses Arnone, D.
 2012
 22 Supplement 2 p. 1-16
16 p.
 artikel
20 Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis de Haas, Ria
 2012
 22 Supplement 2 p. 657-663
7 p.
 artikel
21 Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: Exploration of drug targets through the Stanley Neuropathology Integrative Database Kim, Sanghyeon
 2012
 22 Supplement 2 p. 683-694
12 p.
 artikel
22 Onset, time course and trajectories of improvement with antidepressants Lam, Raymond W.
 2012
 22 Supplement 2 p. S492-S498
7 p.
 artikel
23 P.3.a.004 Artistic expression through an adherence to treatment in schizophrenia Guillena, S.L. Romero
 2012
 22 Supplement 2 p. S305-S306
2 p.
 artikel
24 P.6.a.010 Cognitive disorders among alcoholics: relevance of the Montreal Cognitive Assessment Szprync, M.
 2012
 22 Supplement 2 p. S394-
1 p.
 artikel
25 P.8.a.004 Depersonalisation/derealisation symptoms in social phobia versus controls during acute social stress Crawcour, S.
 2012
 22 Supplement 2 p. S439-
1 p.
 artikel
26 P.2.a.002 Depressive state and personality trait as predictive factors for the suicide risk among the low-income general population Ha, J.H.
 2012
 22 Supplement 2 p. S225-S226
2 p.
 artikel
27 P.2.a.023 Diabetes mellitus type 2: Greek patients' well-being and attitude towards the disease Bakomitrou, F.
 2012
 22 Supplement 2 p. S237-
1 p.
 artikel
28 P.1.a.014 From genes to culture: distribution of dominant affective temperaments in national studies Gonda, X.
 2012
 22 Supplement 2 p. S161-
1 p.
 artikel
29 P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels Madhoo, M.
 2012
 22 Supplement 2 p. S233-S234
2 p.
 artikel
30 P.7.a.014 Methylphenidate effects on social functioning in children with ADHD Carucci, S.
 2012
 22 Supplement 2 p. S421-S422
2 p.
 artikel
31 P.4.a.003 Prevention of relapse in adult patients with generalised anxiety disorder after response to the multimodal psychotropic agent Lu AA21004 Baldwin, D.S.
 2012
 22 Supplement 2 p. S358-S359
2 p.
 artikel
32 P.7.a.011 Tics in children with attention-deficit/hyperactivity disorder under treatment with the sustained-release form of methylphenidate Lakic, A.
 2012
 22 Supplement 2 p. S420-
1 p.
 artikel
33 P.1.a.007 Toll-like receptor 2 polymorphisms are associated with poor concentration in schizophrenia patients in a Korean population Lee, S.M.
 2012
 22 Supplement 2 p. S156-S157
2 p.
 artikel
34 P.3.b.002 A dual rat model of schizophrenia reveals deficiencies in the gene and protein expression at the medial prefrontal cortex and amygdala Gilabert-Juan, J.
 2012
 22 Supplement 2 p. S315-S316
2 p.
 artikel
35 P.3.b.003 Characterization of [3H]-LY508869 – a novel selective metabotropic glutamate 2 positive allosteric potentiator ligand Falcone, J.F.
 2012
 22 Supplement 2 p. S316-
1 p.
 artikel
36 P.6.b.002 Compulsive-impulsive alcohol consumption in serotonin deficient vesicular monoamine transporter 2 (Vmat2) knockout mice Weber, T.
 2012
 22 Supplement 2 p. S395-
1 p.
 artikel
37 P.2.019 BDNF/TrkB signaling in learning and memory: the effects of 7,8-dihydroxyflavone on object memory Bollen, E.
 2012
 22 Supplement 2 p. S47-S48
2 p.
 artikel
38 P.6.b.005 Haplotype tag single-nucleotide polymorphism analysis of the vesicular glutamate transporter 2 gene in severe alcoholism among women Comasco, E.
 2012
 22 Supplement 2 p. S397-
1 p.
 artikel
39 P.4.b.001 Neural correlates of fear conditioning in panic disorder with agoraphobia Lueken, U.
 2012
 22 Supplement 2 p. S367-
1 p.
 artikel
40 P.4.b.004 Repeated dorsal periaqueductal gray injection of corticotrophin-releasing factor facilitates the expression of a panic response Sergio, T. Oliveira
 2012
 22 Supplement 2 p. S369-
1 p.
 artikel
41 P.2.b.005 The effects of the multimodal antidepressant Lu AA21004 on attention and vigilance measured as EEG activity in the rat Sanchez, C.
 2012
 22 Supplement 2 p. S243-S244
2 p.
 artikel
42 P.3.c.023 A naturalistic evaluation of the use of paliperidone palmitate: 6 month interim results on the first 120 patients Taylor, D.M.
 2012
 22 Supplement 2 p. S330-
1 p.
 artikel
43 P.6.c.007 Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use Freeman, T.
 2012
 22 Supplement 2 p. S402-
1 p.
 artikel
44 P.6.c.010 Differences in cannabinoid-induced changes in cognitive performance in light stimulant and cannabis users versus heavy cannabis users Levy-Cooperman, N.
 2012
 22 Supplement 2 p. S403-S404
2 p.
 artikel
45 P.3.c.040 Effect of lurasidone on weight and metabolic parameters: a comprehensive analysis of short- and long-term trials in schizophrenia Pikalov, A.
 2012
 22 Supplement 2 p. S339-S340
2 p.
 artikel
46 P.1.c.023 Effects of the natural 6-styryl-2-pyrone on amino-acid levels in the prefrontal cortex of mice after pentylenetetrazole-induced seizures Vasconcelos, S.M.M.
 2012
 22 Supplement 2 p. S180-
1 p.
 artikel
47 P.2.c.004 Efficacy of quetiapine extended release in major depressive disorder without optimal clinical response to antidepressant treatment Guillena, S.L. Romero
 2012
 22 Supplement 2 p. S252-
1 p.
 artikel
48 P.3.c.013 Examination of switching to aripiprazole and change of metabolic syndrome scale in overweight schizophrenia: 20 weeks prospective study Kim, J.
 2012
 22 Supplement 2 p. S324-
1 p.
 artikel
49 P.2.016 Changes in basal and fluoxetine-induced adult neurogenesis and depression-related behaviours in transgenic S100B over-expressing mice Sousa, V.
 2012
 22 Supplement 2 p. S45-S46
2 p.
 artikel
50 P.3.029 Chronic cannabis use and dopamine synthesis capacity: an [18F]-DOPA positron emission tomography study Bloomfield, M.A.P.
 2012
 22 Supplement 2 p. S76-S77
2 p.
 artikel
51 P.7.c.007 Insulin resistance and metabolic risk related to second-generation antipsychotics in antipsychotic-naïve pediatric and adult patients Díaz-Caneja, C.
 2012
 22 Supplement 2 p. S430-
1 p.
 artikel
52 P.2.c.021 Levomilnacipran in the treatment of major depressive disorder: an analysis of efficacy and safety data from two phase III studies Greenberg, W.
 2012
 22 Supplement 2 p. S262-
1 p.
 artikel
53 P.3.026 Clinical and genetic predictors of antidepressant response and remission in treatment-resistant depression Calati, R.
 2012
 22 Supplement 2 p. S74-
1 p.
 artikel
54 P.2.c.007 Predictors of relapse in a fixed-dose, randomized, double-blind, 52-week relapse prevention trial of selegiline transdermal system Patkar, A.
 2012
 22 Supplement 2 p. S254-
1 p.
 artikel
55 P.3.c.026 Switching antipsychotic treatment in schizophrenic outpatients: results from the ETOS study with focus on quetiapine Roussidis, A.
 2012
 22 Supplement 2 p. S332-
1 p.
 artikel
56 P.7.c.004 Tc-99m TRODAT brain SPECT changes in adolescents with attention deficit hyperactivity disorder after 2 months of methylphenidate therapy Ozek, H.
 2012
 22 Supplement 2 p. S428-S429
2 p.
 artikel
57 P.3.c.027 The effect of antipsychotic drug treatment on serum levels of vascular endothelial growth factor (VEGF), sVEGFR-1, and sVEGFR-2 in schizophrenia Kim, D.H.
 2012
 22 Supplement 2 p. S332-S333
2 p.
 artikel
58 P.1.c.009 The effects of polyamidehydroxyurethane-coated silver nanoparticles on morphine-induced conditioned place preference in rats Ciubotariu, D.
 2012
 22 Supplement 2 p. S171-S172
2 p.
 artikel
59 P.1.d.006 Aggravation of Toll-like receptor-4 (TLR4) mediated sickness behaviour by nucleotide-binding oligomerization domain-2 (NOD2) activation Farzi, A.
 2012
 22 Supplement 2 p. S185-
1 p.
 artikel
60 P.1.001 Deep brain stimulation increases dopamine, serotonin and noradrenaline in the prefrontal cortex van Dijk, A.
 2012
 22 Supplement 2 p. S3-S4
2 p.
 artikel
61 P.2.d.004 Effect of antidepressants and cyclo-oxygenase-2 inhibitor on cytokines and tryptophan metabolites after immune challenge in astrocytes Weiss, A.
 2012
 22 Supplement 2 p. S269-S270
2 p.
 artikel
62 P.1.d.016 Effects of PWZ-029, an α5GABAA receptor inverse agonist, on scopolamine-induced spatial learning deficits in the water maze Joksimovic, S.M.
 2012
 22 Supplement 2 p. S190-S191
2 p.
 artikel
63 P.3.d.008 Glycogen synthase kinase (GSK)-3β signalling pathway in the rodent prefrontal cortex: a role in schizophrenia? Koros, E.
 2012
 22 Supplement 2 p. S348-S349
2 p.
 artikel
64 P.1.d.001 Interoceptive olfactory fear conditioning acquisition and expression is affected by a glucocorticoid agonist Cavalli, J.
 2012
 22 Supplement 2 p. S182-
1 p.
 artikel
65 P.2.d.002 Preclinical effects of Lu AA21004, a novel multimodal antidepressant Mørk, A.
 2012
 22 Supplement 2 p. S268-S269
2 p.
 artikel
66 P.6.e.002 Addiction relation with dopamine 2 receptor (DRD2) Taq1a polymorphism in heroin addicts Yilbas, B.
 2012
 22 Supplement 2 p. S410-S411
2 p.
 artikel
67 P.2.e.002 Depression, cortical excitability and sleep deprivation: a TMS/EEG study Canali, P.
 2012
 22 Supplement 2 p. S276-S277
2 p.
 artikel
68 P.3.e.001 Facial emotion recognition ability pre and post electroconvulsive therapy in schizophrenia patients Varkal, M. Dalkiran
 2012
 22 Supplement 2 p. S350-
1 p.
 artikel
69 P.3.012 Effectiveness of naltrexone in the double blind placebo controlled clinical trial of naltrexone and guanfacine for heroin dependence Palatkin, V.
 2012
 22 Supplement 2 p. S61-S62
2 p.
 artikel
70 P.1.e.016 Ketamine affects brain activation during a visual integration task: a double-blind placebo-controlled pharmaco-fMRI study Höflich, A.
 2012
 22 Supplement 2 p. S201-
1 p.
 artikel
71 P.2.e.005 Korean medication algorithm for bipolar disorder Bahk, W.
 2012
 22 Supplement 2 p. S278-S279
2 p.
 artikel
72 P.2.e.019 Remission of manic and depressive symptoms with asenapine in patients with mixed episodes Azorin, J.M.
 2012
 22 Supplement 2 p. S286-S287
2 p.
 artikel
73 P.6.e.004 Smoking, nicotine dependence and anxiety in medical students Vasylyeva, A.
 2012
 22 Supplement 2 p. S411-S412
2 p.
 artikel
74 P.1.e.013 The Bcl2 gene polymorphism rs956572 modulates anterior cingulate cortex glutamate levels in euthymic subjects with bipolar I disorder Soeiro-de-Souza, M.G.
 2012
 22 Supplement 2 p. S199-S200
2 p.
 artikel
75 P.4.e.009 The decision to engage in exposure predicts attrition: a preliminary examination of the importance of willingness for exposure during cognitive behavioural therapy Gloster, A.
 2012
 22 Supplement 2 p. S378-
1 p.
 artikel
76 P.2.f.006 A comparison of newly diagnosed patients with bipolar I and bipolar II disorder Stoychev, K.
 2012
 22 Supplement 2 p. S295-
1 p.
 artikel
77 P.4.020 Fluoxetine acts not only as an antidepressant: inhibitory effect on murine melanoma growth Grygier, B.
 2012
 22 Supplement 2 p. S99-S100
2 p.
 artikel
78 P.2.g.003 Aripiprazole for the treatment of involuntary movement symptoms in patients with major depressive disorder Cho, A.R.
 2012
 22 Supplement 2 p. S297-
1 p.
 artikel
79 P.1.g.005 Effects of potent nitric oxide-guanylyl cyclase activator and phosphodiesterase-5 inhibitor on cognitive deficits in diabetic rats Utkan, T.
 2012
 22 Supplement 2 p. S207-
1 p.
 artikel
80 P.4.009 Genetic predictors of antidepressant response integrating baseline severity information Tansey, K.E.
 2012
 22 Supplement 2 p. S91-
1 p.
 artikel
81 P.3.010 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3β increases the risk of suicidal behaviour in bipolar patients Jimenez, E.
 2012
 22 Supplement 2 p. S60-S61
2 p.
 artikel
82 P.1.g.019 Glutathione levels at baseline as a predictive biomarker for cognitive functioning at two years follow-up in early onset psychosis Fraguas, D.
 2012
 22 Supplement 2 p. S215-
1 p.
 artikel
83 P.1.i.009 Some urban legends of CNS clinical trial methodology: unsuccessful solutions to the problem of failed trials Williams, J.B.W.
 2012
 22 Supplement 2 p. S223-S224
2 p.
 artikel
84 P.1.018 Modulation of glutamatergic synaptic transmission in prefrontal cortex by 5-HT2A receptors Barre, A.
 2012
 22 Supplement 2 p. S18-S19
2 p.
 artikel
85 Polymorphisms in AKR1C4 and HSD3B2 and differences in serum DHEAS and progesterone are associated with paranoid ideation during mania or hypomania in bipolar disorder Johansson, Anette G.M.
 2012
 22 Supplement 2 p. 632-640
9 p.
 artikel
86 P.2.002 Positive allosteric modulation of metabotropic glutamate 5 receptors prevents and reverses social discrimination deficits in rats Morisot, N.
 2012
 22 Supplement 2 p. S33-S34
2 p.
 artikel
87 Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway McLaughlin, Ryan J.
 2012
 22 Supplement 2 p. 664-671
8 p.
 artikel
88 P.1.002 Role of 5-HT2A-receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow Frånberg, O.I.
 2012
 22 Supplement 2 p. S4-S5
2 p.
 artikel
89 P.1.015 Selective methylation of brain derived neurotrophic factor gene promoter in bipolar disorder: differences between patients and controls Benatti, B.
 2012
 22 Supplement 2 p. S16-
1 p.
 artikel
90 S.07.06 A single dose of the antidepressant fluoxetine modulates emotional processing in young adult volunteers Capitão, L.P.
 2012
 22 Supplement 2 p. S123-
1 p.
 artikel
91 S.11.04 ‘Biased agonism’ at cortical post-synaptic 5-HT1A receptors for improved treatment of depressive disorders Newman-Tancredi, A.
 2012
 22 Supplement 2 p. S128-
1 p.
 artikel
92 S.07.03 Brain activation associated with attentional bias in smokers is modulated by a dopamine antagonist Luijten, M.
 2012
 22 Supplement 2 p. S121-
1 p.
 artikel
93 S.04.01 Differential effects of central oxytocin on social versus cued fear Toth, I.
 2012
 22 Supplement 2 p. S116-
1 p.
 artikel
94 S.07.04 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3β increases the risk of suicidal behaviour in bipolar patients Jimenez, E.
 2012
 22 Supplement 2 p. S122-
1 p.
 artikel
95 S.27.03 Hypocretin/orexin in sleep and mood disorders Fabre, V.
 2012
 22 Supplement 2 p. S145-S146
2 p.
 artikel
96 S.22.03 Positive affect and recovery from depression Wichers, M.
 2012
 22 Supplement 2 p. S140-
1 p.
 artikel
97 S.15.04 Role of baclofen and modulation at GABAB receptor in treating addiction: a clinical prospective Leggio, L.
 2012
 22 Supplement 2 p. S133-S134
2 p.
 artikel
98 S.18.01 The translational neuropharmacology of ketamine Deakin, J.F.W.
 2012
 22 Supplement 2 p. S135-
1 p.
 artikel
99 The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression Caraci, Filippo
 2012
 22 Supplement 2 p. 281-289
9 p.
 artikel
100 The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating Feifel, David
 2012
 22 Supplement 2 p. 374-378
5 p.
 artikel
101 The long-term abnormalities in circadian expression of Period 1 and Period 2 genes in response to stress is normalized by agomelatine administered immediately after exposure Koresh, Ori
 2012
 22 Supplement 2 p. 205-221
17 p.
 artikel
102 The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress Christensen, Jane H.
 2012
 22 Supplement 2 p. 651-656
6 p.
 artikel
103 Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats van de Giessen, Elsmarieke
 2012
 22 Supplement 2 p. 290-299
10 p.
 artikel
104 Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles Kemp, David E.
 2012
 22 Supplement 2 p. 123-131
9 p.
 artikel
                             104 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland